We are monitoring the impact of COVID-19 on Biomarkers Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 164
Share on
Share on

Global Biomarkers Market Size, Share, Trends, COVID-19 Impact and Growth Analysis Report – Segmented By Product, Biomarker Type (Safety Biomarkers, Efficacy Biomarkers), Application, Disease Indications and Region – Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 164
Pages: 175

Biomarkers Market Size (2020 to 2025)

As per the report, the global biomarkers market size is predicted to grow USD 67.33 billion by 2025 from USD 35.84 billion in 2020. This market is showcasing an increasing pace of 13.44% CAGR from 2020 to 2025.

Biomarkers play a crucial role in diagnosing and treating various diseases such as cancer, cardiovascular problems, etc. A combination of biomarkers with novel drugs is evaluating effective treatment procedures for different conditions. With the help of technological advancements, biomarkers are designed to treat neurological diseases by measuring biomolecules that track the brain's health. The launch of biomarker signature makes the treatment of neurological disease easier by diagnosing through non-invasive testing methods. Biomarkers are very safe and give valid results with high precision, and this property is also making the market move forward.

MARKET DRIVERS:

The rising incidence of cancer, growing CROs, and increasing prevalence of chronic diseases worldwide is primarily expanding the global biomarkers market.

In urban areas, people are more likely to adopt sedentary lifestyles, causing a high possibility of being prone to various chronic diseases. Growing chronic disease incidence, majorly cancer, CVDs, and diabetes, are demanding more research initiatives to favor market growth.

Increasing research and development spending, rising healthcare expenditure, and growing demand for biomarkers in the diagnostic field are crucial factors driving growth in the global biomarkers market. Besides, an increasing number of the low costs of clinical trials in emerging countries, growth initiatives in biomarkers research, increasing growth of information technology, growing demand for drug discovery are further propelling the growth of the global biomarkers market.

Increasing initiative steps by government organizations worldwide to reduce the cost of treatment procedures and growing focus on personalized medicine are also lavishing the demand of the biomarkers market. Rising prevalence to increase the productivity of drugs in pharmaceutical companies and peoples demand the prevention of the disease by diagnosing as early as possible further escalates the market growth.

Growing investments in healthcare centers by both public and private organizations, the rise in the priority for the minimally invasive and non-invasive treatment procedures also prompt the demand of this market.

MARKET RESTRAINTS:

Huge investment needs and unfavorable reimbursement rules are major restraints to the global biomarkers market growth. Costs associated with the testing processes are very high, which is estimated to inhibit the market to some extent.

Impact of COVI-19 on the global biomarkers market:

The World Health Organization was declared COVID-19 on March 11, 2020, as a global pandemic and announced healthcare emergence. The recent novel coronavirus causes SARS-COV-2. The emergence of the outbreak has affected almost all sectors of the economy. Pandemic has kept many lives at risk, including nationwide lockdown implemented and a ban on transportation.

The increase in the number of covid-19 positive cases has led to the massive development of the bio-markers technologies market. The molecular markers in the blood are used to prevent the virus and the diseases it causes. Amplified studies have been launched into study results about understanding the pathophysiology and clinical progress of COVID-19. Biomarkers are used for categorizing early infection and individuals who are in danger of increasing critical conditions and requiring hospital care. Biomarkers have played an essential role in clinical decision-making and the number of infectious diseases and treatment procedures. It has become mandatory to access biomarkers to determine the severity of illness and suitable resource allocation.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Product, Type, Application, Disease Indications, and Region.

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities.

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

 

This research report on the global biomarkers market has been segmented based on the product, type, application, disease indications, and region.

Biomarkers Market - By Product:

  • Consumables
  • Software
  • Services

Based on product type, consumables product type is holding the highest shares of the market. Increasing awareness over the utilization of various devices to improve therapeutic procedures elevates the demand for this segment. Rising spending on healthcare is to boost up the growth rate of the market. Also, the increasing popularity of targeted therapies is the demand of the biomarkers market.

Biomarkers Market - By Type:

  • Safety Biomarkers
  • Efficacy Biomarkers
  • Validation Biomarkers

Based on biomarkers type, the Safety biomarkers segment holds the highest shares of the market, whereas efficacy biomarkers are growing tremendously over the past few years. Usage of safe products leads to a high success rate and promotes the well-being of the patient after surgeries are broadening the market demand. People's need for appropriate treatment procedures by diagnosing the disease is also enhancing the growth rate of this market.

Biomarkers Market - By Application:

  • Diagnostics Developments
  • Drug Discovery & Developments
  • Personalized Medicine
  • Disease Risk Assessment

Based on the application, the Diagnostic developments segment is gaining traction over the market shares among all. The rise in capital income in both developed and developing countries are gearing up the market demand. Also, increasing the scale of hospitals is leveraging the growth rate of the market.

Biomarkers Market - By Disease Indications:

  • Cancer
  • Cardiovascular
  • Neurological
  • Immunological Disorders

Based on disease indications, the cancer segment is leading to dominant shares of the market. The increasing geriatric population and rising incidences of cancer diseases are escalating the demand for the biomarkers market. Increasing new cancer patients and the rising number of deaths due to cancer expand the scope for the cancer disease indication segment.

Biomarkers Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

North America held a significant market share of 39.0% of the global biomarkers market in 2019, whereas Asia-Pacific is estimated to grow at the highest CAGR of 16.20% during the forecast period.

KEY MARKET PARTICIPANTS:

Some of the noteworthy companies operating in the global biomarkers market profiled in this report are Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Enzo Biochem (U.S.), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), EKF Diagnostics Holdings plc. (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.)

RECENT MARKET DEVELOPMENTS:

  • In March 2020, Meso Scale Discovery, a Meso Scale Diagnostics division, announced its Biomarkers services at AAPSNational Biotechnology Conference. 
  • In February 2020, Enzo Biochem announced that its subsidiary, Enzo clinical labs, Inc., had received New York State Approval for its CT/NG/Tv tests using liquid-based cytology sample collection on its proprietary Gen-Flex platform. 
  • In February 2020, QGEnN announced the receipt of CE Mark for its therascreen PIK3CA Rotor-Gene Q PCR Kit and its subsequent Europe Launch. 
  • In July 2019, Enzo Biochem Inc. announced several vital transformative initiatives in its lab business unit designed to propel and accelerate the growth. 
  • In August 2018, Enzo Biochem, an integrated diagnostic and therapeutic company, announced implementing its growth strategy. It has agreed to purchase a commercial facility. 
  • In December 2018, Singulex announced the granting of a significant European patent covering methods for determining myocardial. 
  • In April 2016, DiagnoCure Inc. announced that its board of directors has decided, subject to shareholder's approval, to proceed with the voluntary liquidation and dissolution of Quebec's Business Corporations Act. 
  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. Product
      1. Introduction
      2. Consumables
      3. Software
      4. Services
    2. Type
      1. Safety Biomarkers
      2. Efficacy Biomarkers
      3. Validation Biomarkers
    3. Application
      1. Introduction
      2. Diagnostics Developments
      3. Drug Discovery & Developments
      4. Personalized Medicine
      5. Disease Risk Assessment
    4. Disease Condition
      1. Cancer
      2. Cardiovascular
      3. Neurological
      4. Immunological Disorders
  6. Geographical Analysis
    1. North America
      1. Introduction
      2. United States
      3. Canada
    2. Europe
      1. Introduction
      2. U K
      3. Spain
      4. Germany
      5. Italy
      6. France
    3. Asia-Pacific
      1. Introduction
      2. China
      3. India
      4. Japan
    4. Latin America
      1. Introduction
      2. Brazil
      3. Rest of Latin America
    5. Middle East & Africa
      1. Introduction
      2. Middle-East
      3. South Africa
      4. Rest of Middle East & Africa
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Bio-Rad Laboratories (U.S.)
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Qiagen N.V. (Netherlands)
    3. Enzo Biochem (U.S.)
    4. PerkinElmer, Inc. (U.S.)
    5. Merck & Co, Inc. (U.S.)
    6. EKF Diagnostics Holdings plc. (U.S.)
    7. Meso Scale Diagnostics, LLC (U.S.)
    8. Singulex, Inc. (U.S.)
    9. BioSims Technologies (France)
    10. Cisbio Bioassays (France)
    11. Signosis, Inc. (U.S.)
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, collaborations and Joint Ventures
    4. New Product Launches
  10. Expert Opinions
    1. Market Outlook
    2. Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures
  • Global, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges  (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic,economic, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the environmental factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development micro
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Biomarkers Market By Region, From 2019 - 2024 (USD Million)
  2. Global Biomarkers Market By Product, From 2019 - 2024 (USD Million)
  3. Global Consumables Market By Region, From 2020 to 2025 (USD Million)
  4. Global Software Market By Region, From 2020 to 2025 (USD Million)
  5. Global Services Market By Region, From 2020 to 2025 (USD Million)
  6. Global Biomarkers Market By Type, From 2020 to 2025 (USD Million)
  7. Global Safety Biomarkers Market By Region, From 2020 to 2025 (USD Million)
  8. Global Efficacy Biomarkers Market By Region, From 2019 - 2024 (USD Million)
  9. Global Validation Biomarkers Market By Region, From 2020 to 2025 (USD Million)
  10. Global Biomarkers Market By Application, From 2020 to 2025 (USD Million)
  11. Global Diagnostics Development Market By Region, From 2020 to 2025 (USD Million)
  12. Global Drug Discovery and Development Market By Region, From 2020 to 2025 (USD Million)
  13. Global Personalised Medicine Market By Region, From 2020 to 2025 (USD Million)
  14. Global Disease Risk Assessment Market By Region, From 2020 to 2025 (USD Million)
  15. Global Other Applications Market By Region, From 2019 - 2024 (USD Million)
  16. Global Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Million)
  17. Global Cancer Market By Region, From 2020 to 2025 (USD Million)
  18. Global Cardiovascular Disorders Market By Region, From 2020 to 2025 (USD Million)
  19. Global Neurological Disorders Market By Region, From 2020 to 2025 (USD Million)
  20. Global Immunological Disorders Market By Region, From 2020 to 2025 (USD Million)
  21. Global Other Diseases Market By Region, From 2020 to 2025 (USD Million)
  22. North America Biomarkers Market By Region, From 2019 - 2024 (USD Million)
  23. North America Biomarkers Market By Product, From 2020 to 2025 (USD Million)
  24. North America Consumables Market By Region, From 2020 to 2025 (USD Million)
  25. North America Software Market By Region, From 2020 to 2025 (USD Million)
  26. North America Services Market By Region, From 2020 to 2025 (USD Million)
  27. North America Biomarkers Market By Type, From 2020 to 2025 (USD Million)
  28. North America Safety Biomarkers Market By Region, From 2019 - 2024 (USD Million)
  29. North America Efficacy Biomarkers Market By Region, From 2019 - 2024 (USD Million)
  30. North America Validation Biomarkers Market By Region, From 2020 to 2025 (USD Million)
  31. North America Biomarkers Market By Application, From 2020 to 2025 (USD Million)
  32. North America Diagnostics Development Market By Region, From 2020 to 2025 (USD Million)
  33. North America Drug Discovery and Development Market By Region, From 2020 to 2025 (USD Million)
  34. North America Personalised Medicine Market By Region, From 2020 to 2025 (USD Million)
  35. North America Disease Risk Assessment Market By Region, From 2020 to 2025 (USD Million)
  36. North America Other Applications Market By Region, From 2019 - 2024 (USD Million)
  37. North America Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Million)
  38. North America Cancer Market By Region, From 2020 to 2025 (USD Million)
  39. North America Cardiovascular Disorders Market By Region, From 2020 to 2025 (USD Million)
  40. North America Neurological Disorders Market By Region, From 2020 to 2025 (USD Million)
  41. North America Immunological Disorders Market By Region, From 2020 to 2025 (USD Million)
  42. North America Other Diseases Market By Region, From 2020 to 2025 (USD Million)
  43. United States Biomarkers Market By Product, From 2019 - 2024 (USD Million)
  44. United States Biomarkers Market By Type, From 2020 to 2025 (USD Million)
  45. United States Biomarkers Market By Application, From 2020 to 2025 (USD Million)
  46. United States Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Million)
  47. Canada Biomarkers Market By Product, From 2020 to 2025 (USD Million)
  48. Canada Biomarkers Market By Type, From 2020 to 2025 (USD Million)
  49. Canada Biomarkers Market By Application, From 2020 to 2025 (USD Million)
  50. Canada Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Million)
  51. Europe Biomarkers Market By Region, From 2019 - 2024 (USD Million)
  52. Europe Biomarkers Market By Product, From 2020 to 2025 (USD Million)
  53. Europe Consumables Market By Region, From 2020 to 2025 (USD Million)
  54. Europe Software Market By Region, From 2020 to 2025 (USD Million)
  55. Europe Services Market By Region, From 2020 to 2025 (USD Million)
  56. Europe Biomarkers Market By Type, From 2020 to 2025 (USD Million)
  57. Europe Safety Biomarkers Market By Region, From 2019 - 2024 (USD Million)
  58. Europe Efficacy Biomarkers Market By Region, From 2019 - 2024 (USD Million)
  59. Europe Validation Biomarkers Market By Region, From 2020 to 2025 (USD Million)
  60. Europe Biomarkers Market By Application, From 2020 to 2025 (USD Million)
  61. Europe Diagnostics Development Market By Region, From 2019 - 2024 (USD Million)
  62. Europe Drug Discovery and Development Market By Region, From 2019 - 2024 (USD Million)
  63. Europe Personalised Medicine Market By Region, From 2020 to 2025 (USD Million)
  64. Europe Disease Risk Assessment Market By Region, From 2020 to 2025 (USD Million)
  65. Europe Other Applications Market By Region, From 2019 - 2024 (USD Million)
  66. Europe Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Million)
  67. Europe Cancer Market By Region, From 2020 to 2025 (USD Million)
  68. Europe Cardiovascular Disorders Market By Region, From 2020 to 2025 (USD Million)
  69. Europe Neurological Disorders Market By Region, From 2020 to 2025 (USD Million)
  70. Europe Immunological Disorders Market By Region, From 2020 to 2025 (USD Million)
  71. Europe Other Diseases Market By Region, From 2020 to 2025 (USD Million)
  72. Asia-Pacific Biomarkers Market By Region, From 2020 to 2025 (USD Million)
  73. Asia-Pacific Biomarkers Market By Product, From 2020 to 2025 (USD Million)
  74. Asia-Pacific Consumables Market By Region, From 2020 to 2025 (USD Million)
  75. Asia-Pacific Software Market By Region, From 2020 to 2025 (USD Million)
  76. Asia-Pacific Services Market By Region, From 2020 to 2025 (USD Million)
  77. Asia-Pacific Biomarkers Market By Type, From 2020 to 2025 (USD Million)
  78. Asia-Pacific Safety Biomarkers Market By Region, From 2020 to 2025 (USD Million)
  79. Asia-Pacific Efficacy Biomarkers Market By Region, From 2020 to 2025 (USD Million)
  80. Asia-Pacific Validation Biomarkers Market By Region, From 2019 - 2024 (USD Million)
  81. Asia-Pacific Biomarkers Market By Application, From 2020 to 2025 (USD Million)
  82. Asia-Pacific Diagnostics Development Market By Region, From 2020 to 2025 (USD Million)
  83. Asia-Pacific Drug Discovery and Development Market By Region, From 2020 to 2025 (USD Million)
  84. Asia-Pacific Personalised Medicine Market By Region, From 2019 - 2024 (USD Million)
  85. Asia-Pacific Disease Risk Assessment Market By Region, From 2020 to 2025 (USD Million)
  86. Asia-Pacific Other Applications Market By Region, From 2020 to 2025 (USD Million)
  87. Asia-Pacific Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Million)
  88. Asia-Pacific Cancer Market By Region, From 2019 - 2024 (USD Million)
  89. Asia-Pacific Cardiovascular Disorders  Market By Region, From 2020 to 2025 (USD Million)
  90. Asia-Pacific Neurological Disorders Market By Region, From 2019 - 2024 (USD Million)
  91. Asia-Pacific Immunological Disorders Market By Region, From 2020 to 2025 (USD Million)
  92. Asia-Pacific Other Diseases Market By Region, From 2019 - 2024 (USD Million)
  93. China Biomarkers Market By Product, From 2019 - 2024 (USD Million)
  94. China Biomarkers Market By Type, From 2020 to 2025 (USD Million)
  95. China Biomarkers Market By Application, From 2020 to 2025 (USD Million)
  96. China Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Million)
  97. India Biomarkers Market By Product, From 2019 - 2024 (USD Million)
  98. India Biomarkers Market By Type, From 2020 to 2025 (USD Million)
  99. India Biomarkers Market By Application, From 2020 to 2025 (USD Million)
  100. India Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Million)
  101. Japan Biomarkers Market By Product, From 2019 - 2024 (USD Million)
  102. Japan Biomarkers Market By Type, From 2020 to 2025 (USD Million)
  103. Japan Biomarkers Market By Application, From 2020 to 2025 (USD Million)
  104. Japan Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Million)
  105. Latin America Biomarkers Market By Region, From 2019 - 2024 (USD Million)
  106. Latin America Biomarkers Market By Product, From 2019 - 2024 (USD Million)
  107. Latin America Consumables Market By Region, From 2020 to 2025 (USD Million)
  108. Latin America Software Market By Region, From 2020 to 2025 (USD Million)
  109. Latin America Services Market By Region, From 2020 to 2025 (USD Million)
  110. Latin America Biomarkers Market By Type, From 2020 to 2025 (USD Million)
  111. Latin America Safety Biomarkers Market By Region, From 2020 to 2025 (USD Million)
  112. Latin America Efficacy Biomarkers Market By Region, From 2019 - 2024 (USD Million)
  113. Latin America Validation Biomarkers Market By Region, From 2020 to 2025 (USD Million)
  114. Latin America Biomarkers Market By Application, From 2020 to 2025 (USD Million)
  115. Latin America Diagnostics Development Market By Region, From 2020 to 2025 (USD Million)
  116. Latin America Drug Discovery and Development  Market By Region, From 2020 to 2025 (USD Million)
  117. Latin America Personalised Medicine Market By Region, From 2020 to 2025 (USD Million)
  118. Latin America Disease Risk Assessment Market By Region, From 2020 to 2025 (USD Million)
  119. Latin America Other Applications Market By Region, From 2020 to 2025 (USD Million)
  120. Latin America Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Million)
  121. Latin America Cancer Market By Region, From 2020 to 2025 (USD Million)
  122. Latin America Cardiovascular Disorders  Market By Region, From 2020 to 2025 (USD Million)
  123. Latin America Neurological Disorders Market By Region, From 2020 to 2025 (USD Million)
  124. Latin America Immunological Disorders Market By Region, From 2020 to 2025 (USD Million)
  125. Latin America Other Diseases Market By Region, From 2020 to 2025 (USD Million)
  126. Brazil Biomarkers Market By Product, From 2019 - 2024 (USD Million)
  127. Brazil Biomarkers Market By Type, From 2020 to 2025 (USD Million)
  128. Brazil Biomarkers Market By Application, From 2020 to 2025 (USD Million)
  129. Brazil Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Million)
  130. Rest of Latin America Biomarkers Market By Product, From 2019 - 2024 (USD Million)
  131. Rest of Latin America Biomarkers Market By Type, From 2020 to 2025 (USD Million)
  132. Rest of Latin America Biomarkers Market By Application, From 2020 to 2025 (USD Million)
  133. Rest of Latin America Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Million)
  134. Middle East & Africa Biomarkers Market By Region, From 2020 to 2025 (USD Million)
  135. Middle East & Africa Biomarkers Market By Product, From 2020 to 2025 (USD Million)
  136. Middle East & Africa Consumables Market By Region, From 2019 - 2024 (USD Million)
  137. Middle East & Africa Software Market By Region, From 2020 to 2025 (USD Million)
  138. Middle East & Africa Services Market By Region, From 2020 to 2025 (USD Million)
  139. Middle East & Africa Biomarkers Market By Type, From 2020 to 2025 (USD Million)
  140. Middle East & Africa Safety Biomarkers Market By Region, From 2020 to 2025 (USD Million)
  141. Middle East & Africa Efficacy Biomarkers Market By Region, From 2020 to 2025 (USD Million)
  142. Middle East & Africa Validation Biomarkers Market By Region, From 2019 - 2024 (USD Million)
  143. Middle East & Africa Biomarkers Market By Application, From 2020 to 2025 (USD Million)
  144. Middle East & Africa Diagnostics Development Market By Region, From 2020 to 2025 (USD Million)
  145. Middle East & Africa Drug Discovery and Development  Market By Region, From 2020 to 2025 (USD Million)
  146. Middle East & Africa Personalised Medicine Market By Region, From 2020 to 2025 (USD Million)
  147. Middle East & Africa Disease Risk Assessment Market By Region, From 2020 to 2025 (USD Million)
  148. Middle East & Africa Other Applications Market By Region, From 2020 to 2025 (USD Million)
  149. Middle East & Africa Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Million)
  150. Middle East & Africa Cancer Market By Region, From 2020 to 2025 (USD Million)
  151. Middle East & Africa Cardiovascular Disorders  Market By Region, From 2020 to 2025 (USD Million)
  152. Middle East & Africa Neurological Disorders Market By Region, From 2020 to 2025 (USD Million)
  153. Middle East & Africa Immunological Disorders Market By Region, From 2020 to 2025 (USD Million)
  154. Middle East & Africa Other Diseases Market By Region, From 2020 to 2025 (USD Million)
  155. Middle East Biomarkers Market By Product, From 2020 to 2025 (USD Million)
  156. Middle East Biomarkers Market By Type, From 2020 to 2025 (USD Million)
  157. Middle East Biomarkers Market By Application, From 2020 to 2025 (USD Million)
  158. Middle East Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Million)
  159. South Africa Biomarkers Market By Product, From 2020 to 2025 (USD Million)
  160. South Africa Biomarkers Market By Type, From 2020 to 2025 (USD Million)
  161. South Africa Biomarkers Market By Application, From 2020 to 2025 (USD Million)
  162. South Africa Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Million)
  163. Rest of Middle East & Africa Biomarkers Market By Product, From 2020 to 2025 (USD Million)
  164. Rest of Middle East & Africa Biomarkers Market By Type, From 2020 to 2025 (USD Million)
  165. Rest of Middle East & Africa Biomarkers Market By Application, From 2020 to 2025 (USD Million)
  166. Rest of Middle East & Africa Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample